The purpose of this medicine is to provide a boost to the body's immune system to help it destroy cancer cells, specifically non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), biliary tract cancer, unresectable hepatocellular carcinoma, bladder cancer, and endometrial cancer
It is strictly prohibited for human consumption or therapeutic use
Animal models suggest that BPC 157 may support recovery by influencing tissue repair pathways involved in cellular migration, wound closure, and functional recovery
The lowest-documentation sources marketplace listings without manufacturer identification, lot tracking, or COA availability carry the highest rate of independent testing failures
The effectiveness depends on several factors, including individual response, health conditions, and the type of injection
The 2026 Prohibited List, Section S2.2.3 (Growth hormone, its analogs and fragments)